GCL
ORIAU

Glazer Capital LLC’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Glazer Capital LLC’s Portfolio ORIAU Stock Details ORIAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-416
Closed -$4K – 797
2022
Q1 		$4K Sell
416
-209,294
-100% -$2.05M ﹤0.01% 546
2021
Q4 		$2.05M Sell
209,710
-30,390
-13% -$302K 0.05% 322
2021
Q3 		$2.38M Sell
240,100
-7,970
-3% -$79.6K 0.04% 379
2021
Q2 		$2.49M Buy
+248,070
New +$2.5M 0.04% 405

Other funds holding ORIAU

JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Glazer Capital LLC's ORIAU Position: Q2 2022 in Review

Glazer Capital LLC sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q2 2022, closing a stake of 416 shares — an estimated $4K sold.

Glazer Capital LLC first reported a position in ORIAU in Q2 2021 and held it in 4 quarters. The position peaked at $2.49M in Q2 2021. 11 funds tracked by Wall St. Rank hold ORIAU as of Q2 2022.

  • Glazer Capital LLC reported no remaining Orion Biotech Opportunities Corp. Units position as of Q2 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 416 Orion Biotech Opportunities Corp. Units shares in Q2 2022, an estimated $4K.
  • Glazer Capital LLC first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 4 quarters.
  • Glazer Capital LLC's Orion Biotech Opportunities Corp. Units position peaked at $2.49M in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q2 2022.

Based on Glazer Capital LLC's 13F filing for Q2 2022, filed 15 Aug 2022.